It's a matter of who's making there reputation. Goldman Sachs and Morgan Stanley are better salesmen than Dave Gentry and Crocker Coulson...simple as that. I do believe that Goldman Sachs and Morgan Stanley will be selling some CCME in due time. I think CME would have been better off raising capital through GS or MS rather than CV Starr, but nonetheless, GS and MS are buying shares, and they'll help drive us to better valuations if the company continues on it's current growth trajectory.. Big funds want things that are scaleable, and when you're bringing in 30+MM in cash per quarter, that counts.
There is no reason this stock shouldn't be trading in the $30's or higher other than not enough people know and understand the company's story. That will come, and has already started.. Just because we've pulled back a bit doesn't change that we're trading considerably higher than two months ago. Enough people know this story to let it go back down to 52 week lows, and I doubt we see much if any downside from here.
News 
Market Data 
Discover 
